The Alzheimer's Association says that "we're in an era of treatments now," which is excellent, but these treatments aren't suitable for everyone with Alzheimer's. That's why I'm excited that I have been approached by start-ups that are looking at treatments from a different angle. We've got InmuneBio targeting the immune cells in the brain, and today, I'm speaking with Sara Holt of BioVie, a clinical-stage company developing a novel approach to treating Alzheimer's disease.
In this episode, you'll learn about Biovie's work and how it could affect us in the near future. You'll hear Sarah's story first, which led her to work with them. This is an inspirational and informative episode that is very fascinating.
BioVie believes targeting neuroinflammation could be the key to finding an effective Alzheimer's therapy. Their lead compound, NE3107, aims to modulate inflammation and improve energy metabolism in the brain. NE3107 is now in Phase 3 clinical trials, with results expected in late 2023. On today's show, we'll discuss BioVie's unique approach, how NE3107 works, and the progress of its clinical program.
We'll also examine the evidence linking inflammation to Alzheimer's progression and why some experts believe this represents an untapped target for drug development. With over 6 million Americans living with Alzheimer's and only recent potential treatments approved, BioVie's research offers additional hope.
Join us as we explore whether NE3107 could pave the way to the first new class of Alzheimer's drugs in years. Learn more at BioViePharma.com.
Please help us keep our show going by supporting our sponsors. Thank you.
Make Your Brain Span Match Your LifeSpan
With Relevate nutritional supplement, you get science-backed nutrition to help protect your brain power today and for years to come. You deserve a brain span that lasts as long as your lifespan.
Join Fading Memories On Social Media!
If you've enjoyed this episode, please share this podcast with other caregivers! You'll find us on social media at the following links.
Contact Jen at email@example.com